Evidence map›Paper›PMID 10951584›Full record

ArticleOncogene2000

Notch(ic)-ER chimeras display hormone-dependent transformation, nuclear accumulation, phosphorylation and CBF1 activation.

C Ronchini, A J Capobianco

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.International journal of clinical and experimental pathology · 2015
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. It's T-ALL about Notch.Oncogene · 2008
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

C RonchiniDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, College of Medicine, Ohio 45267-0524, USA.
A J Capobianco
University of Cincinnati · USUniversity of Cincinnati Medical Center · US

Funding

MOLECULAR MECHANISMS OF NOTCH SIGNALING IN NEOPLASIAR01CA083736 · NCI · WISTAR INSTITUTE · PI CAPOBIANCO, ANTHONY JOHN · 2000 to 2016
$4.0M
NCI NIH HHS R0I CA 83736
6 · The paper itself

Abstract

Notch genes encode a family of evolutionarily conserved transmembrane receptors that are involved in many distinct cellular processes such as differentiation, proliferation and apoptosis. Notch function has been shown to be required both during development and in adult life. Moreover, several studies on spontaneous human tumors and in experimental models demonstrate that three of the four mammalian Notch genes can act as oncogenes. The mechanism by which Notch proteins induce neoplastic transformation is not known. In order to determine the early signaling events mediated by Notch during cellular transformation we constructed several inducible alleles of Notch(ic) by fusing portions of Nic to the hormone-binding domain of the estrogen receptor. Here we show that Notch(ic)-ER chimeras are conditionally activated by 4-Hydroxytamoxifen (OHT) in a dose-dependent manner. Clonal RKE cell lines expressing Notch(ic)-ER chimeras display hormone-dependent transformation in vitro. Transformation mediated by Notch(ic)-ER is reversible and chronic stimulation is necessary for the maintenance of the transformed phenotype. In response to hormone activation Notch(ic)-ER chimeras become hyperphosphorylated and accumulate in the nucleus of the cell; indicating that both phosphorylation and nuclear localization are required for Notch transforming activity.

Indexed as

Saccharomyces cerevisiae ProteinsAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell LineCell NucleusCell Transformation, NeoplasticDNA-Binding ProteinsDose-Response Relationship, DrugEstrogen AntagonistsFungal ProteinsHormonesHumansKidneyMembrane ProteinsPhosphorylationRatsafimoxifeneBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCBF1 protein, S cerevisiaeDNA-Binding ProteinsEstrogen AntagonistsFungal ProteinsHormonesMembrane ProteinsReceptors, EstradiolReceptors, NotchRecombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsTamoxifen

Identifiers

PMID10951584
OpenAlexW2324617025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.